Sector consensus Virax Biolabs Group Limited

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 16/06/2026 BST			5-day change	1st Jan Change
0.1570 ^USD	-9.20%		-16.58%	-54.60%

05-26	Virax Biolabs Group Limited Reports Positive Early Clinical Data for Viraximmune in Long Covid and Related Post-Acute Infection Syndromes	CI
03-18	Virax Biolabs Group Limited Approves Fourth Amended and Restated Memorandum and Articles of Association	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
VIRAX BIOLABS GROUP LIMITED	-	-	1	+536.94%	1
LONZA GROUP AG			663.52	+34.21%	23
REVOLUTION MEDICINES, INC.			187.29	+19.61%	21
BEONE MEDICINES AG			412.35	+56.24%	27
IQVIA HOLDINGS INC.			226.95	+26.67%	19
CELLTRION, INC.			252,919.41	+44.94%	24
MEDPACE HOLDINGS, INC.			442.83	-4.07%	12
EUROFINS SCIENTIFIC SE			70.89	+13.02%	14
IONIS PHARMACEUTICALS, INC.			104.57	+43.06%	23
ICON PUBLIC LIMITED COMPANY			153.25	+6.76%	16
TEMPUS AI, INC.			66.53	+31.59%	15
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			212.27	+14.87%	15
BIO-TECHNE CORPORATION			61.69	+10.11%	13
ABIVAX			108.4	+29.74%	6
QIAGEN N.V.			43.82	+17.73%	14
ALKERMES PLC			46.12	+4.62%	16
PRAXIS PRECISION MEDICINES, INC.			627.59	+143.96%	17
PROTAGONIST THERAPEUTICS, INC.			118.69	+7.28%	13
Average			14,248.18	+57.63%	16
Weighted average by Cap.			23,707	+30.74%	19